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A B S T R A C T
Antibiotic resistant bacterial communities persist in many types of wounds, chronic wounds in particular, in the
form of biofilms. Biofilm formation is a major cause of severe infections and the main reason for a negative
treatment outcome and slow healing progression. Chronic wounds are a silent epidemic essentially affecting
people with co-morbid conditions such as diabetes and obesity and elderly persons particularly those with
movement limitations. The development of complementary and alternative effective strategies to antibiotics for
the treatment of chronic wounds is highly desired. Phage therapy constitutes a very promising approach in the
control of topical microbial populations. In this work newly isolated phages were tested for their efficacy to
control bacterial species that predominate in chronic wounds. Phage effectiveness was studied on 24-h old
biofilms formed in polystyrene microplates and in porcine skin explants using two treatment approaches: in-
dividual phage and a cocktail of phages against four main pathogens commonly isolated from chronic wounds.
The two models produced variations in the surface colonization ability, assessed by viable bacterial counts and
microscopy visualization after using peptide nucleic acid (PNA) or locked nucleic acid probes (LNA) and 2′-O-
methyl (2′-OMe) in fluorescence in situ hybridization (FISH), and in the phage-host interactions. Phages alone
and combined caused greater reductions in the number of viable cells when biofilms had been formed on porcine
skins and with greater variations detected at 4 h and 24 h of sampling. These results suggest that porcine skin
models should be preferentially used to assess the use of phages and phage cocktails intended for topical use in
order to understand the fate, throughout treatment time, of the population when dealing with biofilm-related
infections.
1. Introduction
A wound is an injury to living tissue and depending on the evolution
of the healing process, it can be divided into acute and chronic. Acute
wounds follow the normal healing process (hemostasis, inflammation,
granulation, epithelization, and maturation) (Ammons, 2010), restoring
the anatomical and functional integrity of the injured site, as opposed to
chronic wounds that remain stagnant in a state of inflammation for a
period of six weeks or more (Ammons, 2010; Wolcott et al., 2008a,b).
These wounds, that do not follow a timely and orderly healing process
of the injured site, represent a silent epidemic that affects a large
fraction of the world population and poses a major threat to public
health and the economy (Sen et al., 2009). In developed countries, it is
estimated that 1 to 2% of the population will have a chronic wound
during their lifetime (Gottrup, 2004), due to the increase in lifestyle
diseases such as diabetes, obesity and cardiovascular diseases and also
due to the increasing proportion of elderly population (Price et al.,
2009; Sen et al., 2009). The chronicity of the wounds is largely due to
ischemia (restriction in blood supply) resulting in lack of oxygen in the
cells (hypoxia), intrinsic factors of the host, and bacterial infections.
The latter are responsible for the inflammation and continuous de-
struction of the tissues, which limits wound healing (Rhoads et al.,
2012; Wolcott et al., 2008a,b).
All wounds are susceptible to infections and development of mi-
crobial communities in the wound bed, referred to as biofilms (Percival
et al., 2012). Biofilms are a set of microorganisms that aggregate on
biotic or abiotic surfaces and grow in community, surrounded by a
matrix of extracellular polymer substances (EPS) that microorganisms
secrete (Hall-Stoodley and Stoodley, 2009; Stewart and William
Costerton, 2001). Biofilms are an important survival strategy of the
microorganisms, and their presence in wounds is considered the main
reason why venous, pressure and diabetic ulcers progress to chronic
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conditions, and why they are so difficult to control either by im-
munological response or by antimicrobial therapy (Percival et al.,
2012). The reduced metabolic activity of cells in biofilms is also a
survival strategy since metabolically quiescent biofilm cells survive
antimicrobials because these agents require energy to eliminate cells
(Fux et al., 2005). In addition, the great majority of antimicrobials are
designed to act on microorganisms in the exponential growth phase,
which makes their use in biofilms impracticable (Mascio et al., 2007).
The microbial flora of chronic wounds changes over time. Gram-
positive bacteria predominate, in the first phases of an infection, and
many of these are common in normal skin flora (e.g. Staphylococcus
aureus and β-hemolytic streptococci such as Streptococcus pyogenes and
Streptococcus agalactiae) (Thevanesam, 2013). At a later stage, gram-
negative bacteria (e.g. Pseudomonas spp. and Acinetobacter spp.) are the
main species present. Long-term wounds are also colonized by anae-
robic species, due to the invasion of bacteria into the deeper structures
of the tissues (bones and muscles) (Thevanesam, 2013). The most
common facultative anaerobic gram-negative bacteria in chronic
wounds are Proteus spp., Escherichia coli and Klebsiella spp., which re-
present between 30% and 62% of the total bacteria present (Gjødsbøl
et al., 2006; Rhoads et al., 2012). The number of microorganisms re-
quired to cause an infection largely depends on the type of micro-
organisms present, since certain bacteria, in small numbers, produce
enzymes that contribute to the debridement of the wound. S. aureus, P.
aeruginosa and β-hemolytic streptococci are known to cause delayed
healing and infection as they produce highly destructive virulence
factors (Gooderham and Hancock, 2009; Neves et al., 2018).
Bacterial infection plays an important role in the inability to heal,
that can be decreased with appropriate treatments that include sup-
pression of biofilm formation and maturation (Wolcott et al., 2008a,b),
and also a biofilm prevention strategy (Thevanesam, 2013). The so-
cioeconomic impact that wounds have on the population requires new
treatment strategies that allow healing of these wounds in order to
improve human health and reduce treatment costs.
Bacteriophages, also referred to as phages, are bacterial viruses that
specifically infect. Phages can be categorised into virulent or temperate
depending on their lifecycle. Virulent phages have a replication cycle
that ends in the lysis of bacterial host to release the newly formed phage
particles and these are the phages suited for therapeutic applications
(Sillankorva and Azeredo, 2014). The constant evolution of multi-
resistant bacteria to antibiotics has motivated the scientific community
to reevaluate phage therapy in bacterial infections (Górski et al., 2016).
The reimplementation of phage therapy may become a good choice or
complementary alternative to commonly used therapeutic drugs, since
these are natural antibacterials capable of regulating the growth of
exponential and stationary phase cells and can control biofilms (Melo
et al., 2016; Oliveira et al., 2017; Oliveira et al., 2018; Pires et al.,
2017). Compared with antibiotics, phages have multiple advantages,
such as: i) action against multiresistant pathogens; ii) specificity that
will consequently not affect the resident cutaneous microflora; iii) low
potential for adverse effects not affecting animal cells; iv self-reprodu-
cing capacity; v) easy of isolation for the majority of pathogens in-
volved in wound infections; vi) low production cost; and vii) greater
effectiveness against stationary and biofilm cells (Oliveira et al., 2015;
Pires et al., 2015).
In vitro biofilm models have provided substantial evidence that
phages are able to control biofilm populations (Melo et al., 2016; Pires
et al., 2011; Sillankorva et al., 2008a). However, biofilm formation on
abiotic surfaces, fail in simulating the functional characteristics of
biofilms formed in wounds. Notwithstanding that in vivo models are the
best to understand wound infection and healing following antimicrobial
therapy, there are some ethical and economic constraints associated to
their use (Ganesh et al., 2015; Seaton et al., 2015). To overcome these
constraints, ex vivo wound models have been developed using animal
skin that resemble more closely the characteristics of biofilms formed in
this context. These skins provide the surface for microbial attachment
and the primary source of their nutrition. (Percival et al., 2012). For
instance, Alves et al. (2018) used an ex vivo porcine skin combined with
a custom burn wound array device to evaluate the potential of phages
to control biofilm formation by Staphylococcus aureus. In a previous
study, we used an ex vivomodel adapted from da Costa et al., 2015, and
this model proved to be suitable for the evaluation of phages alone and
combined with honey against mono- and dual species biofilms of E. coli
and Pseudomonas aeruginosa (Oliveira et al., 2018). However, all these
models, including the one we previously used, require fresh porcine
skin explants for the experiments demanding controlled skin harvest
schedules with the animal research facilities, conducted under strict
ethical requirements, which is not always compatible with the research
experiments. Furthermore, in our previous model, biofilms were formed
on the space between the rubber o-rings and the intact porcine skin
explant (see Fig. S1), which better represents a closed type of wound or
mild wound such as an abrasion wound. The present model mimics an
open wound, where an inicision was made in the epidermis and dermis
layers, in order to simulate biofilm formation with proliferation to
deeper skin tissue layers (Yang et al., 2013). This ex vivomodel provides
a more accurate human open skin wound replica to assess biofilm for-
mation and provides a better understanding how these can be con-
trolled using phages, alone and in cocktail against four specific patho-
gens commonly isolated from infected wounds.
2. Materials and methods
2.1. Bacteria and media
The clinical isolates used in this study were provided by the Hospital
de Braga (Braga, Portugal). In total, 12 strains of Acinetobacter bau-
mannii, 7 strains of P. aeruginosa and 31 strains of E. coli were used.
Also, 2 Proteus mirabilis (SGSC 5460, SGSC 5461) and 2 previously
characterized P. mirabilis phages (Melo et al., 2016) were used in this
study. All strains were grown in TSB medium. The solid medium used
was TSA consisting of TSB and 1.5% (w/v) agar, and the top agar layer
contained TSB and 0.6% (w/v) agar. The media were prepared ac-
cording to the manufacturer's instructions and sterilized (121 °C,
15min). All bacterial strains were preserved in glycerol and stocks
maintained at −80 °C.
2.2. Verification of the presence of intact temperate phages in bacterial
strains
All strains tested were verified for the presence of temperate phages
before use in the enrichment procedures using a procedure previously
described (Sillankorva et al., 2010). This verification rules out any false
positive results that may interfere in the phage isolation outcomes.
Briefly, 100 μl of each strain, grown overnight at 37 °C, were mixed
with 3ml of TSA top agar and poured onto a Petri dish containing TSA.
The top agar was allowed to solidify and then 20 μl drops of all strains
of each species were placed on the top agar layer. After the drops had
dried, the Petri dishes were incubated overnight at 37 °C and the pre-
sence of lysis zones was evaluated. Effluent enrichment was performed
with those bacterial combinations that did not result in lysis areas when
spotted in the other tested strains.
2.3. Phage isolation
Phage isolation was performed as described previously (Sillankorva
et al., 2008b). In brief, raw sewage was collected from a wastewater
treatment plant (Frossos, Braga), centrifuged (9000×g, 4 °C, 10min)
and filtered (0.45 µm pore size) to remove solid particles. The filtered
raw sewage (60ml) was placed in sterile 500ml flasks with double
strength TSB. To this mixture, 50 µl of each overnight grown bacteria
were added and the flasks incubated at 37 °C with shaking
(120–180 rpm) for 24 h. The enriched effluents were centrifuged
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(9000×g, 4 °C, 10min) and the supernatant collected and filtered
(0.2 μm). The spot test on bacterial lawns was used to assess if the
enriched effluents had phages. Briefly, 100 μl of overnight grown bac-
teria and 3ml of top agar were poured on a TSA plate and the top agar
layer was allowed to solidify. After, 20 μl of the enriched effluent were
placed and the drop allowed to dry. The plates were incubated over-
night at 37 °C. On the following day, the presence or absence of lysis
areas (clear and turbid) on the plate, indicators of presence or absence
of phage, respectively, were observed. All positive results were further
assessed to isolate phages with varied plaque morphologies and were
further streaked thrice to guarantee purity of the phage plaques.
2.4. Phage propagation and titration
Phages were amplified using the plate lysis and elution method
adapted from Sambrook and Russel (2001) that has been described
previously (Sillankorva et al., 2008b). Titration of the phage was per-
formed as described previously (Adams, 1959).
2.5. Phage host range and selection of phages
The host range specificity was assessed as described previously
using the spot test, spotting up to 1000-fold diluted phage suspensions
(Melo et al., 2016). The plating results were described as: positive (+)
when lysis-from-within or as LO when lysis-from-without were ob-
served; and negative (−) when phages were not able to infect the
bacterium. The selection of phages for further experiments was based
on the host range of phages and infectivity towards the bacteria pre-
senting higher resistances to commonly used antibiotics (see Tables 2–4
for percentages of resistance and Tables S1–S4 for their respective
susceptibility to different antibiotics tested).
2.6. In vitro biofilm formation and infection
A pre-inoculum (500 µl) grown overnight at 37 °C (120 rpm) was
used to inoculate 10ml of TSB medium until an optical density OD620
between 0.2 and 0.3 was reached, which corresponds to approximately
1× 108 CFU·ml−1 of each bacterial strain in study. TSB (200 µl) and
1 µl of bacterial culture were added to 96-well microplates and in-
cubated at 37 °C, under static conditions during 24 h. After that, the
medium was removed and the wells washed twice with PBS (8 g·l−1
NaCl, 0.2 g·l−1 KCl, 0.2 g·l−1 K2HPO4, 2.85 g·l−1 NaHPO4·12H2O) to
remove planktonic cells, sonicated for 5min using an ultrasound water
bath (Sonic model SC-52, UK) operating at 50 kHz, serially diluted and
plated to determine the number of viable cells (CFUs). For phage in-
fection experiments, after washing with PBS, 100 µl of phage or phage
cocktail at different multiplicities of infection (MOI), detailed in
Table 1, were added and the 96-well plates were incubated at 37 °C
under static conditions. For control experiments, instead of a phage
solution, SM buffer (5.8 g·l−1 NaCl, 2 g·l−1 MgSO4·7H2O, 50ml 1M
Tris, pH 7.5) was added to the wells. After 4 and 24 h of infection, the
phage solution and SM buffer were removed from three treated and
three control wells, respectively, and washed twice with 100 µl of PBS.
After washing, 100 µl of saline (NaCl 0.9% (w/v)) were added to each
well, the microplates were sonicated for 5min in an ultrasound water
bath (Sonic model SC-52, UK) operating at 50 kHz, being the wells also
scraped thoroughly to detach the biofilm, serially diluted and plated to
determine the amount of CFUs. Control samples were performed with
100 µl of SM buffer. Four independent experiments in triplicate were
performed.
2.7. Preparation of the porcine skin
Porcine skin sheets from the backs of pigs were obtained from a
local abbatoir after slaughter and prior to scalding and flaming since
this was shown by Yang and colleagues (2013) to destroy the epidermis
layer. The skins were immediately sterilized using chlorine gas as de-
scribed previously (Yang et al., 2013). Briefly, skins were washed with
10% (v/v) bleach during 5min. After this, the skins were placed in a
desiccator for 45min in the presence of chlorine gas created due to the
reaction between 20ml of acetic acid and 10ml of commercial grade
bleach. The reaction was stopped with 30ml of 1.6 mM Na2CO3. Sub-
sequently, skins were washed four times with sterile PBS. The excess of
PBS was removed by vacuum aspiration. After, 10mm×10mm
squares were cut with a scalpel with an approximate thickness of
4–6mm, and using a biopsy punch (3.5mm diameter) a hole was cre-
ated in the skin, to mimic more closely a wound, with a depth of ap-
proximately 1.5 mm (Fig. 1). Skin squares were then frozen (-20 °C)
until further use.
2.8. Ex vivo biofilm formation and infection
A bacterial culture at OD620 between 0.2 and 0.3 was grown as
described above, and after this, 10 µl of this culture was added in the
hole, previously created using the biopsy punch, of each skin. The skin
explants were put on TSA plates with 0.5% (w/v) agar and incubated
during 24 h at 37 °C with 5% CO2 and saturated humidity. The explants
were washed twice with PBS to remove loosely adhered cells and put in
a 15ml tube with 5ml of PBS, sonicated (30 s, 20W), and serially di-
luted and plated to quantify CFUs before phage challenge. For the
phage infection experiments, after washing, each skin was placed in a
24-well plate with either 1ml of a single phage or 1ml of a phage
cocktail (2 to 3 phages, depending on the tested species) using the MOIs
detailed in Table 1. The 24-well plates were incubated at 37 °C under
static conditions, and after, three treated and three control skin samples
were removed at 4 and 24 h. These skins were washed twice with PBS,
sonicated (30 s, 20W), serially diluted and plated to quantify the
amount of CFUs. Control experiments were performed using 100 µl of
SM buffer without phages. Six independent experiments in triplicate
were performed for E. coli, and five for A. baumannii, P. aeruginosa and
P. mirabilis.
2.9. Hystological sectioning of porcine skins
Biofilms in porcine skins were fixed with 4% (v/v) paraformalde-
hyde and stored at 4 °C for 24 h until histological processing. Porcine
skins were placed in cassettes, dehydrated, paraffin wax-embedded, cut
into 3–5 μm sections (HM 325, Microm, Walldorf, Germany) and placed
in microscopy slides (Histobond, Raymond A Lamb, Eastbourne, UK).
Before hybridization with different probes, microscope slides were de-
waxed and hydrated adapting a previously described protocol
(Cerqueira et al., 2011). In brief, sections were immersed in xylol,
ethanol and water, allowed to air dry, and then were subjected to the
hybridization (Almeida et al., 2009; Vilas Boas et al., 2016).
Table 1
Single phage and phage cocktails used in the E. coli, A. baumannii, P. aeruginosa,
and P. mirabilis biofilm control experiments and the respective MOIs used in the
experiments.
Host+ reference strain or clinical
isolate nr.
Phage MOI single
strategy
MOI cocktail
strategy
E. coli EC7 EC7a 100 100
EC7b – 1
EC3a – 1
A. baumannii AB2 P2 100 100
P1 – 1
AB7a – 1
P. aeruginosa PA1 PA1 100 100
PA4 – 1
P. mirabilis SGSC 5460 Pm5460 100 100
Pm5461 – 1
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2.10. Hybridization of samples for microscopy imaging
Different types of probes were used for the Fluorescence in situ
hybridization (FISH) procedure performed on biofilms according to the
available types already in our Centre. Peptide Nucleic Acid (PNA)
probes were used for E. coli and P. mirabilis while for A. baumannii and
P. aeruginosa Locked Nucleic Acid (LNA) and 2′-O-methyl probes (2′-
OMe) (see Table S5 for details). Histological sections were covered
either with 50 μl of PNA hybridization (10% (w/v) dextran sulphate,
10mM NaCl, 30% (v/v) formamide, 0.1% (w/v) sodium pyropho-
sphate, 0.2% (w/v) polyvinylpyrrolidone, 0.2% (w/v) FICOLL, 5mM
disodium EDTA, 0.1% (v/v) Triton X-100 and 50mM Tris-HCl, and
200 nM of probe) or 50 μl of LNA hybridization solution (900mM NaCl,
30% (v/v) formamide, 20mM Tris-HCl (pH 7.2), 0.01% (w/v) sodium
dodecyl sulfate, and 200 nM of probe). Samples were covered with
coverslips, placed in Petri dishes with a moist absorbent paper,
Table 2
Lytic spectrum of the isolated phages against E. coli clinical isolates.
Clinical
isolate Origin Antibiogram
a Phages
EC1 EC3a EC3b EC7a EC7b EC9 EC20
EC1 Urine 6.7 + - - - - - -
EC2 Urine 0.0 + LO LO LO LO LO -
EC3 Blood 6.7 + + + + + + +
EC4 Urine 0.0 + - - - - - -
EC5 PF 0.0 - - - - - LO -
EC6 Urine 20.0 - - - - - - -
EC7 Urine 6.7 + + + + + + +
EC8 Urine 0.0 + + + + + + -
EC9 Urine 6.7 - - - - + + +
EC10 Urine 26.7 - - - - - - -
EC11 Catheter 6.7 - - - - - - -
EC12 Urine 13.3 - LO + LO LO - -
EC13 PF 60.0 - - - - - LO LO
EC14 Blood 60.0 LO LO LO LO LO LO -
EC15 Urine 0.0 + - + - - - -
EC16 Blood 13.3 - - - - - - -
EC17 PF 26.7 + - - - - - -
EC18 Urine 6.7 - - - - - - -
EC19 Urine 0.0 + + + LO LO LO -
EC20 Blood 20.0 + + + + - - +
EC21 Urine 6.7 - - - - - - -
EC22 Urine 0.0 + - + LO - - +
EC23 Urine 20.0 + + LO + + LO LO
EC24 Blood 0.0 + - - - - - -
EC25 Urine 0.0 + - - - - - -
EC26 Urine 13.3 - - - - - - -
EC27 Urine 0.0 - - - - - - -
EC28 Urine 20.0 - - - - - - -
EC29 Urine 6.7 - LO - LO LO - -
EC30 Urine 0.0 - LO - LO LO - -
EC31 Urine 6.7 - + + + + + +
Infection (%) 48,4 38,7 38,7 41,9 38,7 35,5 25,8
PF Peritoneal fluid; (+) Presence of phage plaque; (−) Absence of phage plaque; LO: Lysis from without;
aPercentage of resistance to antibiotics detailed in Tables S1 and S2; Highlights in grey indicate the host of
the different phages.
Table 3
Lytic spectrum of phages isolated against clinical isolates of A. baumannii.
Isolate Origin Antibiograma PhagesAB1 AB3 AB6a AB6b AB7a AB7b AB8 P1b P2 b
AB1 BA 75.0 + + + + + + +
AB2 Sputum 37.5 - - - - - - -
AB3 BA 75.0 + + + + + + +
AB4 Urine 0.0 - - - - - - -
AB5 Urine 0.0 - - - - - - -
AB6 BA 75.0 + + + + + + +
AB7 BA 75.0 + + + + + + + + +
AB8 Urine 37.5 + + + + + + +
AB9 Sputum 0.0 - - - - - - -
AB10 Urine 37.5 + + + + + + +
AB11 Sputum 0.0 - - - - - - -
AB12 SE 50.0 - - - - - - -
Infection 
(%) 50 50 50 50 50 50 50
BA Bronchial aspirate; SE Skin exudate; (+) Presence of phage plaque; (−) Absence of phage plaque; LO:
Lysis from without; aPercentage of resistance to the antibiotics detailed in Table S3. bOnly tested for the strain
AB7. Highlights in grey indicate the host of the different phages.
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wrapped in aluminium foil and incubated at a hybridization tempera-
ture of 59 °C for 90min (Almeida et al., 2009; Vilas Boas et al., 2016).
After, the coverslip was removed and slides washed with pre-heated
specific wash solutions (WS) during 30min at 59 °C to remove unbound
probes. The WS used had different composition according to the type of
probe used: for PNA probes the WS contained 5mM Tris Base, 15mM
NaCl, 1% (v/v) Triton-X while for LNA probes the WS was 20mM Tris-
HCl (pH 7.2), 0.01% SDS (v/v) and 900mM NaCl.
To visualize biofilms formed on polystyrene surfaces, 24-well mi-
croplates were washed with PBS and biofilms fixed to the polystyrene
adding 4% (v/v) paraformaldehyde during 30min. After, the paraf-
ormaldehyde was removed, samples washed with 50% ethanol (v/v)
and allowed to air dry at room temperature. The wells were then cut
with a heated scalpel (1 cm×1 cm squares) and the hybridization
procedure was then carried out as described above.
2.10.1. Microscopy imaging of biofilms on porcine skin and polystyrene
After the hybridization process, samples were washed, and allowed
to air dry in the dark, mounted with one drop of non-fluorescent im-
mersion oil (Merck) and covered with coverslips. Porcine tissues were
stained with 50 μl of a 1 μg/ml solution of 4′, 6-diamidino-2-pheny-
lindole (DAPI) during 10min, in the dark, and allowed to dry for 5min.
Microscopy imaging was performed using an epifluorescence micro-
scope (Olympus BX51) coupled with a DP71 digital camera and three
sets of filters (DAPI – 365–370/421; FITC – 470–490/516; and TRITC –
530–550/591) (Olympus Portugal SA, Porto, Portugal). All images were
acquired using the Olympus Cell-B software.
2.11. Statistical analysis
Statistical analysis of the results was performed using GraphPad
Prism 6. Mean and standard deviations (SD) were determined for the
independent experiments and the results were presented as
mean ± SD. Results within samples were compared using two-way
ANOVA, with Tukey’s multiple comparison statistical test. Differences
were considered statistically different if p≤ 0.05 (95% confidence in-
terval). Results between surfaces were compared determining the p
value using the multiple t tests program if GraphPad Prism 6 and sta-
tistical significance was determined using the Holm-Sidak methos with
an alpha of 0.05.
3. Results
3.1. Presence of intact temperate phages
A few spotted P. aeruginosa clinical isolates resulted in lysis areas
indicating microbial growth inhibition and, therefore, were not used for
the effluent enrichment procedures. No lysis areas were observed for
the E. coli and A. baumannii strains used (data not shown).
3.2. Lytic spectra
Lytic spectra of all isolated phages were performed to select the
phages for posterior use in the control of biofilms. The criteria used for
this selection were host spectrum and the ability to infect the strains
showing highest antibiotic resistance. Antibiograms of each strain are
detailed in Tables S1–S4. The phages were named according to the
bacterial strain from which they were isolated (for example, phage EC2
was isolated from E. coli (EC) clinical isolate number 2). Phage plaques
with different morphologies obtained from an isolate were named after
the isolation host to which was added a letter at the end, e.g. phage
EC3a.
For E. coli, 7 phages were isolated using the clinical isolates.
According to Table 2, phage EC1 was able to infect the largest number
Table 4
Lytic spectrum of the isolated phages against P. aeruginosa clinical isolates.
Clinical isolate Origin Antibiograma Phages
PA1 PA4 PA6 PA7
PA1 Cutaneous 0.0 + - - -
PA2 Sputum 14.3 LO - - -
PA3 Sputum 7.1 LO + + +
PA4 Urine 7.1 + + + +
PA5 Urine 42.9 - + - +
PA6 Urine 42.9 + + + +
PA7 Sputum 0.0 + + + +
Infection (%) 85.7 71.4 57.1 71.4
(+) Presence of phage plaque; (−) Absence of phage plaque; LO: Lysis from without; aPercentage of strain
resistance to the antibiotics detailed in Table S4. Highlights in grey indicate the host of the different phages.
Fig. 1. Porcine skin explant model of chronic wounds (A) Schematic representation of a longitudinal cut of the porcine skin and the respective sizes; (B) porcine skin
before use; (C) Petri dish with solid TSB media (1.2% agar) containing three porcine skins after 24 h of incubation with bacteria (E. coli).
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of strains, 48.4%, while phage EC20 had the narrowest lytic spectrum,
infecting only 25.8% of the strains tested. Lysis of some strains was due
to lysis from without (LO), e.g. EC5, EC13, EC14, EC29 and EC30. This
list of strains includes two clinical isolates showing 60% resistance to
15 antibiotics, isolates EC13 and EC14, respectively (see Table S2).
Eight of the isolates, presenting antibiotic resistance between 0 (com-
pletely sensitive, isolate EC10) to 26.7% (EC27), were not infected by
any phage, not even due to LO. Although phage EC1 infected the
highest number of bacterial strains, its production revealed to be very
challenging and the successive productions performed resulted in
maximum titers below the necessary for further experiments and
therefore this phage was discarded from further experiments. Phage
EC3a has been previously characterized (Oliveira et al., 2017) and
presents clear plaques (2.63mm in diameter) surrounded by a halo
[total plaque size (plaque+halo)= 11.55mm]. Morphology and
genomic characterization of EC3a showed that it belongs to the Sipho-
viridae family. Contrarily to this phage, phages EC7a and EC7b, do not
present halo and both formed clear plaques that were 2.20 ± 0.05mm
and 2.75 ± 0.25mm in diameter, respectively.
Seven phages were isolated for A. baumannii, and their efficacy
tested in 12 clinical isolates (Table 3). Regardless of the resistance to
different antibiotics (see Table S3), all isolated phages infected the
same A. baumannii isolates – AB1, AB3, AB6, AB7, AB8, and AB10,
respectively. All other isolates were not infected, not even due to LO.
The phage presenting the highest plaque and halo was AB7. Since there
was no difference in lytic spectra, two previously isolated and char-
acterized phages - Podoviridae phages P1 and P2 that have shown to
infect strains from the A. calcoaceticus – A. baumannii complex (Oliveira
et al., 2017) were tested only on bacterial lawns of AB7. Both phages
formed clear plaques on these lawns and were, together with phage
AB7a, chosen for the experiments using a phage cocktail. Phage AB7a
presents a clear plaque that only increases until 24 h, reaching a dia-
meter of 5.00 ± 0.35mm surrounded by a halo that increased every
day. At day 1 the diameter of the plaque+halo was approximately
1.2 cm and by day 5 this diameter was already of 2.8 cm. The plaque
characteristics of the other phages have already been described
(Oliveira et al., 2017).
For P. aeruginosa, 4 phages were isolated and their lytic spectrum
was tested against 7 clinical isolates (Table 4). Phage PA1 infected the
highest number of tested strains, 85.7%, 2 of which due to LO, followed
by phages PA4 and PA7, which infected 71.5% of the strains. All phages
infected the clinical strain (PA6), showing 42.9% resistance towards the
antibiotics tested, while only PA4 and PA7 were capable of infecting the
strain PA5, that also presented 42.9% resistance. Phages PA1 and PA4
were selected for the cocktail approach and their plaques characterized
morphologically. Phage PA1 had very small clear plaques with
1.3 ± 0.10mm in diameter, and phage PA4 presented clear plaques
but larger in diameter (2.2 ± 0.25mm).
The P. mirabilis phages used, Pm5460 and Pm5461, have been
previously characterised and belong to the Podoviridae and Myoviridae
families, respectively (Melo et al., 2016).
3.3. Biofilm control
In this work, E. coli, P. aeruginosa, A. baumannii, and P. mirabilis
biofilms were formed on polystyrene microplates and porcine skins.
Infection was performed using a single phage or a phage cocktail con-
taining 2 or 3 phages (Table 1), and samples were evaluated after 4 h
and 24 h of infection.
In E. coli experiments, the control surfaces (non-phage treated sur-
faces) taken at 4 h and 24 h showed an 0.8 and 3.0 log CFU·cm−2 sta-
tistically higher (p < 0.005, and p < 0.05, respectively) colonization
of porcine skins compared to polystyrene (see differences in control
columns in Fig. 2). Both single phage EC7a and the phage cocktail
applied to biofilms formed on porcine skins led to significant reductions
(p < 0.05). Maximum cells reductions at 4 h and 24 h (1.9 and 2.3 log
CFU·cm−2) were obtained with EC7a alone but these were not statis-
tically significant (p > 0.05) from the ones obtained with the phage
cocktail. Phage control of biofilms formed on polystyrene showed lower
cell reduction by phages which varied between reduction of 0.8 and
1.0 CFU·cm−2 after 4 h and reductions of 1.4 and 1.1 CFU·cm−2 after
24 h using EC7a alone and the phage cocktail, respectively (Fig. 2).
A. baumannii colonized control porcine skins had slightly more cells
than the polystyrene microplates but these differences were not statis-
tically significant (p > 0.05). At 4 h of infection of biofilms formed on
porcine skin, a significant reduction (p < 0.05) of viable cells using
AP2 phage (1.4 log CFU·cm−2 reduction) and using the phage cocktail
(2.2 log CFU·cm−2 reduction) were observed compared to control
samples. Furthermore, treatment with the phage cocktail was sig-
nificantly better (p < 0.05) than with phage AP2 alone (Fig. 3). At 24 h
of infection, both phage AP2 alone and the phage cocktail led to non-
significant decreases with cell counts comparable to those obtained for
control samples (p > 0.05) due to a great increase of cells from 4 h to
24 h of treatment. On polystyrene, the application of both single phage
and the phage cocktail had similar effects with somewhat low reduc-
tions which fall below 1.0 log CFU·cm−2 at all tested conditions. No
major difference was observed between the two time points (4 h and
24 h), respectively. A. baumannii phages were more successful in con-
trolling biofilms formed in porcine skin samples than in the polystyrene
surface, however only during a short treatment period.
P. aeruginosa colonization was significantly higher in porcine skin
than in polystyrene being the difference in cell levels of 0.4 and 2.4 log
CFU·cm−2 at 4 h and 24 h (p < 0.05 at 4 h and p < 0.001 at 24 h),
respectively. Both phage PA1 alone and the phage cocktail reduced
significantly (p < 0.05) the levels of P. aeruginosa present on porcine
skins at 4 h, however, only PA1 alone was also able to reduce sig-
nificantly (p < 0.05) at 24 h of infection (Fig. 4). At 24 h, the phage
cocktail consisting of two phages (phages PA1 and PA4) was ineffective
in killing P. aeruginosa from porcine skins, resulting in bacterial loads
similar to those observed in the controls. On the other hand, P. aeru-
ginosa biofilms grown on polystyrene were equally infected by the
single phage and the phage cocktail. However, both of these strategies
led to only slight reductions in viable cells, which were not statistically
significant compared to the control samples (p > 0.05).
P. mirabilis experiments showed a 1.0 log CFU·cm−2 statistically
higher colonization of porcine skins than polystyrene surfaces at 4 h
(p < 0.001) and at 24 h (p < 0.05), respectively. Application of both
single phage Pm5460 and the phage cocktail (phages Pm5460 and
Pm5461) on biofilms formed on porcine skins led to only slight de-
creases in the number of viable cells at 4 h of infection (< 0.65 log
CFU·cm−2) (Fig. 5). At 24 h of infection, biofilm cells were better re-
duced using phage Pm5460 alone (1.0 log CFU·cm−2 reduction),
however, this reduction was not statistically significant (p > 0.05)
compared to the one obtained using the phage cocktail. Contrarily to all
other phage-host systems studied, phages were more efficient in redu-
cing biofilms at 4 h from polystyrene surfaces, resulting in 1.0 and 1.8
log CFU·cm−2 lower levels of cells using the single and cocktail phage
solutions, respectively, when compared to the controls. However,
prolonging the treatment to 24 h resulted in an increase of viable cells
to levels similar to the ones observed in the control samples.
3.4. Microscopy imaging of biofilms formed on porcine skin sections and
polystyrene
Epifluorescence microscopy imaging was performed after PNA-FISH
or LNA-FISH procedures using specific probes (Table S5). Both porcine
skins and polystyrene after their in vitro contamination with bacteria
(Figs. 6 and 7) were visualized.
Thin micrometre sections, that were 3 to 5 µm thick covering sam-
ples from the 3.5mm wide biopsy punch area of porcine skins, con-
firmed that cells adhered to these surfaces and were found living in
biofilm communities. Portions of biofilms were found attached
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particularly to the irregularities of porcine skins as observed in the
microscopy sections. The P. aeruginosa skin sections analysed after LNA-
2′-OMe-FISH showed only a few rod shaped cells that seemed to be
more located in the EPS matrix than actually adhered to the skins
(please see Fig. 7C and Fig. S4), and therefore this made analysis more
difficult since no large clusters (as observed in Fig. 7A, B and D) were
present. Additional porcine skin sections are provided in Figs. S2–S5.
Microscopy imaging of polystyrene surfaces corroborate that E. coli
is the pathogen that forms biofilms with less cells present (Fig. 7). These
cells are dispersed in the surfaces and in some small areas cells were
found aggregated in microcolonies, (Fig. 7A). A. baumannii cells were
stained in red due to the Cy5 conjugated to the probe used. Sample
areas analysed showed differences in colonization with some areas
more heavily colonized, presenting apparently different layers, and
other areas that had cells sparsely distributed, and even some propor-
tions of the surface that had no cells attached (Fig. 7B and Fig. S7).
Biofilms of P. aeruginosa tended to aggregate in specific areas leaving
other areas completely uncontaminated (Fig. 7C and Fig. S8). Biofilm
cells of P. mirabilis were dispersed throughout the surface and appeared
to be present in different layers since only some appeared focused while
others only appeared focused when the working distance between
sample and objectives were changed (Fig. 7D and Fig. S9). Additional
microscopy images of the surfaces are also provided as Supplementary
Material (see Figs. S6–S9).
4. Discussion
Although the potential of phage therapy has been well demon-
strated in the last years (Chhibber et al., 2013; Mendes et al., 2013; Seth
et al., 2013), limited studies have been reported using ex vivomodels. In
vitro models using abiotic surfaces are easily reproducible but may not
accurately reflect the efficacy of antimicrobial compounds on, for in-
stance, biofilms found in wounds (Yang et al., 2013). A better approach
to produce biofilms that more closely resemble the characteristics of
biofilms found in wounds can rely on the use of pig skin as the at-
tachment surface as well as the primary source of nutrients. The porcine
skin ex vivomodel includes valuable characteristics such similarity with
human skin anatomy and physiology, and the fact that it is suitable for
several trials at an affordable price (Schmook et al., 2001; Sullivan
et al., 2001).
Fig. 2. Number of viable cells (CFU·cm−2) present in E. coli EC7 24-h old biofilms formed on porcine skin samples and 96-well polystyrene plates, before (0 h) and
after exposure to single phages or to the phage cocktail for 4 and 24 h. C – control; SP – single phage; CP – cocktail of phages.
Fig. 3. Number of viable cells (CFU·cm−2) present in A. baumannii AB2 24-h biofilms formed on porcine skin samples and 96-well polystyrene plates, before (0 h) and
after exposure to single phages or to the phage cocktail for 4 and 24 h. C – control; SP – single phage; CP – cocktail of phages.
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In a previous work, we reported the use of phages in an ex vivo
model where biofilms were also formed in porcine skins (Oliveira et al.,
2018). However, there are major differences between this model and
the one used in the present work (see Fig. 1 and Fig. S1). In our previous
study, we used a model that more closely mimics a mild abrasion
wound since no injuries were made on the porcine skin surfaces (Fig.
S1). In the model presented herein, a cavity was created in the porcine
skins to allow biofilm formation in depth, emulating more truthfully
contaminated and heavily contaminated wounds (Fig. 1).
The results obtained with the ex vivo model used herein were also
compared with biofilms formed in vitro (polystyrene plates). The phages
used target pathogens frequently found associated to wound infections.
These include two pathogens (A. baumannii and P. aeruginosa) of the
ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and
Enterobacter species) group - the leading group of pathogens involved in
nosocomial infections worldwide. This study also includes two
Enterobacteriaceae (E. coli and P. mirabilis). Bacteria from this family
have become increasingly more resistant to carbapenem and carba-
penem-resistant Enterobacteriaceae (CRE) are, according to CDC re-
sponsible for the death in up to 50% of patients who become infected
(CDC, 2018). In 2017, the World Health Organization (WHO) listed a
priority list of pathogens to ensure research and development of new
antibiotics for 12 families of bacteria that pose the greatest threat to
human health. In this list, first priority or critical priority, as described
by WHO, is needed for:1) A. baumannii, 2) P. aeruginosa, and 3) En-
terobacteriaceae, CRE, extended-spectrum beta-lactamases (ESBL) pro-
ducing bacteria (WHO, 2017). Despite the polymicrobial aetiology of
Fig. 4. Number of viable cells (CFU·cm−2) present in P. aeruginosa PA1 24-h biofilms formed on porcine skin samples and 96-well polystyrene plates, before (0 h) and
after exposure to single phages or to the phage cocktail for 4 and 24 h. C – control; SP – single phage; CP – cocktail of phages.
Fig. 5. Number of viable cells (CFU·cm−2) present in P. mirabilis 5460 24-h biofilms formed on porcine skin samples and 96-well polystyrene plates, before (0 h) and
after exposure to single phages or to the phage cocktail for 4 and 24 h. C – control; SP – single phage; CP – cocktail of phages.
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chronic wound infections (Frank et al., 2009), only monospecies biofilm
populations of these four pathogens were investigated to simplify spe-
cimen processing and data analysis.
It is a known fact that the surface chosen for biofilm formation has
influence in the biofilm structure, physiology and composition (Nadell
et al., 2016; Qi et al., 2018), and also in gene expression (Prigent-
Combaret et al., 1999; Ren et al., 2004; Southey-Pillig et al., 2005). The
colonization of the two studied surfaces varied greatly and pathogen
loads were always superior on the biological surface (porcine skins)
than on polystyrene. Hydrophobicity of surfaces can promote/decrease
cell attachment (Katsikogianni and Missirlis, 2004). Both surfaces
tested herein are hydrophobic, having similar water contact angles,
with porcine skins exhibiting an angle of 91° (Elkhyat et al., 2004), and
polystyrene angles between 90° and 94° (Bekele and Tsige, 2013;
Bergslien et al., 2004). The use of polystyrene for biofilm growth can
only be used for nonaffixing cells such as bacteria (Curtis et al., 1983;
Dowling et al., 2011). In our experiments, cell colonization of porcine
skins could possibly be enhanced due to the nutrients provided by the
skin itself but also due to the greater roughness that increases the
overall surface area for colonisation as confirmed by the location of
microbial biofilm formation in the histological porcine skin sections
assessed by microscopy (Fig. 6). The differences in biofilm formation
may interfere in the interaction of phages with their host bacteria since
it appears that biofilm cells in porcine skin explants are closer and this
might enhance their elimination by phages.
Due to the difference in surface colonization, and in order to allow
comparisons, not only between species but also between surfaces tested,
the ratio of phage to host was always maintained constant regardless of
the surface tested – the MOI was 100 for the phage applied alone and
this MOI was also kept for this phage when applied in the cocktail to-
gether with other phage(s) that was(were) added at a MOI of 1. As
already expected, phages were able to reduce more viable cells after 4 h
than at 24 h, corroborating previous studies using other phages and
their hosts (Carson et al., 2010; Melo et al., 2016; Pires et al., 2011).
Reductions at 4 h using a single phage on biofilms formed on porcine
skins varied from 0.64 log CFU·cm−2 (P. mirabilis) to 2.48 log
CFU·cm−2 (P. aeruginosa), while the combination of phages (2 or 3
phages) resulted in viable cell reductions in the range of 0.41 log
CFU·cm−2 (P. mirabilis) to 2.30 log CFU·cm−2 (P. aeruginosa). The in-
crease of treatment time was only beneficial for E. coli where the phages
continued to decrease the number of viable cells, particularly in the
experiments carried out using the ex vivo model. The efficacy of phages
against E. coli biofilms formed in vitro was overall lower than ex vivo,
despite using the same initial MOIs (adjusted to the initial viable cell
concentration of the biofilms that was optimized prior to phage appli-
cation studies). The use of a phage cocktail was not much different than
using phage alone. It was expected that the presence of a phage pos-
sessing depolymerase activity, such as EC3a that is present in the E. coli
phage cocktail, would grant a final higher effect on viable cells but this
was not the case. This result was expected since phages encoding de-
polymerases are described to have a better access to the host receptors
due to degradation of the EPS that not only increases cell death but also
promotes phage diffusion to other layers of the biofilm (Pires et al.,
2016).
The greatest differences towards control of biofilms formed in vitro
and ex vivo were perceived after 4 h using E. coli, A. baumannii, and P.
Fig. 6. Microscopy imaging of histological porcine skin sections colonized with the different pathogens stained with the probes described in Table S5. (A) E. coli EC7,
(B) A. baumannii AB2, (C) P. aeruginosa PAO1, (D) P. mirabilis 5460. Skin tissues were stained with DAPI. Scale bar corresponds to 20 µm. P. aeruginosamicrographs do
not present a scale bar but images were taken using the same amplification.
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aeruginosa phages. In these samples phages were able to reduce higher
numbers of cells from porcine skins than from polystyrene. The most
similar effect of phages against biofilms formed in both surfaces was
obtained using E. coli phages which in general reduced above 1.0 log
CFU·cm−2 of biofilm cells. The only species where phages showed
slightly better efficacy in vitro than ex vivo, particularly after 4 h, was P.
mirabilis. These contrasting/similar results may be due to the differ-
ences/similarities in biofilm structure and composition, and amount of
EPS matrix present in the biofilms formed in these two surfaces. For
instance, when the level of EPS increases this may compromise phage
recognition of the host through masking of its receptors.Further ex-
periments need to be performed to validate this hypothesis. In the case
of P. mirabilis, besides biofilm structure and composition, there may
also be differences in swarming ability of this bacterium in the two
surfaces. It has been previously described that P. mirabilis swarming
ability changed simply by changing the type of catheter that served as
surface for cell adhesion (Hola et al., 2012). These authors tested 102
Proteus isolates and showed greatest swarming when Kendall Catheter-
type Curity catheters were used (91.2%), while worst swarming was on
Meditec Foley catheters (2%). Swarming is a flagella-driven surface
migration behaviour that confers bacteria capacity to rapidly colonize
nutritionally rich environments, such as porcine skin, facilitating
colony spread and accelerating biomass production (Rather, 2005) to
form crystalline biofilms which may prevent phage adsorption to the
host receptors (Melo et al., 2016). According to a previous study,
swarming of Proteus spp. compromised phages diffusion through bio-
film matrix (Carson et al., 2010), leading to a more difficult killing
ability of phages. These studies corroborate our findings that Proteus
biofilms formed on porcine skins have possibly better swarming
conditions than in polystyrene and therefore we observed better phage
activity in the latter surface.
In theory, the reductions caused by phages can be further increased
in in vivo conditions due to the innate immune response which will
work synergistically with phages to eliminate bacteria as demonstrated
previously through a mechanism described as immunophage synergy
(Hodyra-Stefaniak et al., 2015; Leung and Weitz, 2017; Roach et al.,
2017). Roach et al. (2017) showed that neutrophil-phage synergy is
essential for the resolution of pneumonia being neutrophils involved in
clearing in vivo phage susceptible and phage resistant variants, that
phages were immunologically well tolerated and that phages were not
cleared by immune effector cells.
5. Conclusions
In summary, some of the phages isolated and tested in this work
significantly impaired biofilm formation of several pathogens in a
model which mimics an infected open wounds, highlighting their po-
tential as alternative or complementary treatment agents to control
wound infections.
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